Good news for Botox lovers: Allergan will be offering its first ever consumer rebates on the wrinkle-fighting drug. The move comes after Allergan saw a 6.1% drop in fourth-quarter profit. The company is getting ready to lay off 5% of its workforce.
Allergan said it decided to offer a $50 consumer rebate off Botox Cosmetic treatments, which usually cost several hundred dollars. It is also the first year since Botox Cosmetic was approved in 2002 that the company hasn't raised the price to physicians. A similar program will be offered to encourage sales of the company's dermal filler, called Juvederm.
Mr. Pyott said the programs are designed to promote cross-selling opportunities in physicians' offices as Allergan begins rolling out Latisse, a new product that promotes eyelash growth.
Latisse is going to be very popular, especially when the economy turns around and consumers have more money to spend.